BRPI0719394A2 - Preparação medicinal sólida - Google Patents
Preparação medicinal sólidaInfo
- Publication number
- BRPI0719394A2 BRPI0719394A2 BRPI0719394A BRPI0719394A2 BR PI0719394 A2 BRPI0719394 A2 BR PI0719394A2 BR PI0719394 A BRPI0719394 A BR PI0719394A BR PI0719394 A2 BRPI0719394 A2 BR PI0719394A2
- Authority
- BR
- Brazil
- Prior art keywords
- medicinal preparation
- solid medicinal
- solid
- preparation
- medicinal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006330374 | 2006-12-07 | ||
PCT/JP2007/073550 WO2008072534A1 (ja) | 2006-12-07 | 2007-12-06 | マンニトール又は乳糖を含有する固形製剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0719394A2 true BRPI0719394A2 (pt) | 2015-03-31 |
Family
ID=39511554
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0719394 BRPI0719394A2 (pt) | 2006-12-07 | 2007-12-06 | Preparação medicinal sólida |
Country Status (9)
Country | Link |
---|---|
US (1) | US20100004279A1 (pt) |
EP (1) | EP2100609A4 (pt) |
JP (1) | JP5289975B2 (pt) |
KR (1) | KR101442862B1 (pt) |
CN (1) | CN101600430A (pt) |
BR (1) | BRPI0719394A2 (pt) |
CA (1) | CA2672134C (pt) |
TW (1) | TWI428151B (pt) |
WO (1) | WO2008072534A1 (pt) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI482641B (zh) * | 2006-12-07 | 2015-05-01 | Daiichi Sankyo Co Ltd | 含有低取代度羥丙基纖維素之醫藥組成物 |
CA2823981C (en) * | 2006-12-07 | 2016-05-17 | Daiichi Sankyo Company, Limited | Film-coated preparation having improved stability |
KR101442862B1 (ko) | 2006-12-07 | 2014-09-22 | 다이이찌 산쿄 가부시키가이샤 | 만니톨 또는 유당을 함유하는 고형 제제 |
CA2672154C (en) * | 2006-12-07 | 2014-11-18 | Daiichi Sankyo Company, Limited | Pharmaceutical composition having improved storage stability |
MX2010014209A (es) * | 2008-06-20 | 2011-02-21 | Merck Patent Gmbh | Matriz de comprimidos de compresion directa y rapida desintegracion. |
SI2398468T1 (sl) * | 2009-02-17 | 2017-03-31 | Krka, D.D., Novo Mesto | Farmacevtske sestave, ki obsegajo prasugrel ali njegove farmacevtsko sprejemljive kislinske adicijske soli in postopek za njihovo pripravo |
JP2012180280A (ja) * | 2009-05-28 | 2012-09-20 | Daiichi Sankyo Co Ltd | 貯蔵安定性が改善された固形製剤 |
DE102009036646A1 (de) * | 2009-08-07 | 2011-02-10 | Ratiopharm Gmbh | Prasugrel in nicht-kristalliner Form und pharmazeutische Zusammensetzung davon |
EP2360159A1 (de) * | 2010-02-11 | 2011-08-24 | Ratiopharm GmbH | Prasugrel in mikronisierter, kristalliner Form und pharmazeutische Zusammensetzung davon |
CN102232949A (zh) | 2010-04-27 | 2011-11-09 | 孙远 | 提高药物溶出度的组合物及其制备方法 |
MD4117C1 (ro) * | 2010-07-30 | 2012-02-29 | Институт Химии Академии Наук Молдовы | Pudră cu capacitate hemostatică şi regenerativă (variante) şi procedeu de obţinere a acesteia |
CN102885774B (zh) * | 2011-07-18 | 2014-03-12 | 李勤耕 | 普拉格雷组合物及其制备方法 |
CZ2011872A3 (cs) | 2011-12-22 | 2013-07-03 | Zentiva, K.S. | Farmaceutická formulace prasugrelu hydrobromidu |
US8603537B2 (en) | 2012-04-02 | 2013-12-10 | Egis Pharmaceuticals Plc | Prasugrel containing quickly released stable oral pharmaceutical compositions |
KR102092002B1 (ko) * | 2012-04-27 | 2020-03-23 | 메르크 파텐트 게엠베하 | 코팅이 있는 정제 및 이의 제조 |
CN103565773B (zh) * | 2012-08-07 | 2017-12-05 | 广东东阳光药业有限公司 | 一种盐酸普拉格雷的药物组合物 |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5015480A (en) * | 1987-11-25 | 1991-05-14 | Eli Lilly And Company | Film coating formulations |
US5211958A (en) * | 1987-11-30 | 1993-05-18 | Gist-Brocades, N.V. | Pharmaceutical composition and process for its preparation |
US4931286A (en) * | 1989-04-19 | 1990-06-05 | Aqualon Company | High gloss cellulose tablet coating |
FI101150B (fi) * | 1991-09-09 | 1998-04-30 | Sankyo Co | Menetelmä lääkeaineina käyttökelpoisten tetrahydrotienopyridiinin johd annaisten valmistamiseksi |
ZA937382B (en) * | 1992-10-06 | 1994-04-29 | Warner Lambert Co | Novel composition for peroral therapy of cognitionimpairment and a process therefor |
JP3583166B2 (ja) * | 1994-06-27 | 2004-10-27 | 興和株式会社 | 損傷皮膚修復用粉末製剤 |
GB9414045D0 (en) * | 1994-07-12 | 1994-08-31 | Berwind Pharma Service | Moisture barrier film coating composition, method, and coated form |
NZ330864A (en) * | 1996-02-29 | 2001-07-27 | Fujisawa Pharmaceutical Co | Beta-lactam antibiotic-containing tablet including a disintegrant and a binder |
JPH10310586A (ja) * | 1996-06-26 | 1998-11-24 | Sankyo Co Ltd | ヒドロピリジン類の新規医薬用途 |
KR100343062B1 (ko) * | 1996-11-15 | 2002-07-02 | 에가시라 구니오 | 정제 조성물 |
TWI249526B (en) * | 1998-03-13 | 2006-02-21 | Aventis Pharma Inc | Novel processes for the preparation of (R)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol |
CA2374760A1 (en) * | 1999-06-18 | 2000-12-28 | Takeda Chemical Industries, Ltd. | Quickly disintegrating solid preparations |
EP1133984B1 (en) * | 2000-03-17 | 2005-05-11 | Shin-Etsu Chemical Co., Ltd. | Solid preparation containing low-substituted hydroxypropyl cellulose and production process thereof |
FR2807034B1 (fr) * | 2000-03-29 | 2002-06-14 | Roquette Freres | Mannitol pulverulent et son procede de fabrication |
CA2342121C (fr) * | 2000-03-29 | 2010-05-25 | Roquette Freres | Mannitol pulverulent et son procede de preparation |
JP4001199B2 (ja) * | 2000-07-06 | 2007-10-31 | 第一三共株式会社 | ヒドロピリジン誘導体酸付加塩 |
CZ302990B6 (cs) * | 2000-07-06 | 2012-02-08 | Daiichi Sankyo Company, Limited | Adicní soli derivátu hydropyridinu s kyselinou chlorovodíkovou a maleinovou, príprava a použití |
ATE371439T1 (de) * | 2000-07-27 | 2007-09-15 | Roquette Freres | Granulat bestehend aus stärke und laktose |
AU2002217464B2 (en) * | 2000-12-25 | 2004-12-16 | Daiichi Sankyo Company, Limited | Medicinal compositions containing aspirin |
JP4874482B2 (ja) * | 2000-12-25 | 2012-02-15 | 第一三共株式会社 | アスピリンを含有する医薬組成物 |
KR100908418B1 (ko) * | 2001-06-20 | 2009-07-21 | 액티버스 파마 컴퍼니 리미티드 | 퀴놀리논 유도체 의약 조성물 및 그의 제조 방법 |
JP4029974B2 (ja) * | 2001-12-21 | 2008-01-09 | 第一三共株式会社 | ヒドロピリジン誘導体酸付加塩を含有する医薬 |
JP2004051639A (ja) * | 2002-07-18 | 2004-02-19 | Sankyo Co Ltd | 動脈硬化症治療のための医薬組成物 |
US20050192245A1 (en) * | 2002-07-18 | 2005-09-01 | Sankyo Company, Limited | Medicinal composition for treating arteriosclerosis |
CN1681533A (zh) * | 2002-07-18 | 2005-10-12 | 三共株式会社 | 用于治疗动脉硬化的药用组合物 |
WO2004091600A1 (ja) * | 2003-04-16 | 2004-10-28 | Kyorin Pharmaceutical Co., Ltd. | 経口固形製剤 |
JP2006525328A (ja) * | 2003-05-05 | 2006-11-09 | イーライ リリー アンド カンパニー | 心疾患の治療方法 |
KR100882156B1 (ko) * | 2003-08-08 | 2009-02-06 | 아지노모토 가부시키가이샤 | 나테글리니드 함유 제제 |
TWI318571B (en) * | 2005-06-10 | 2009-12-21 | Lilly Co Eli | Formulation of a thienopyridine platelet aggregation inhibitor |
KR101442862B1 (ko) | 2006-12-07 | 2014-09-22 | 다이이찌 산쿄 가부시키가이샤 | 만니톨 또는 유당을 함유하는 고형 제제 |
TWI482641B (zh) * | 2006-12-07 | 2015-05-01 | Daiichi Sankyo Co Ltd | 含有低取代度羥丙基纖維素之醫藥組成物 |
CA2823981C (en) * | 2006-12-07 | 2016-05-17 | Daiichi Sankyo Company, Limited | Film-coated preparation having improved stability |
CA2672154C (en) * | 2006-12-07 | 2014-11-18 | Daiichi Sankyo Company, Limited | Pharmaceutical composition having improved storage stability |
-
2007
- 2007-12-06 KR KR1020097011283A patent/KR101442862B1/ko active IP Right Grant
- 2007-12-06 JP JP2008549267A patent/JP5289975B2/ja active Active
- 2007-12-06 TW TW096146466A patent/TWI428151B/zh active
- 2007-12-06 US US12/312,972 patent/US20100004279A1/en not_active Abandoned
- 2007-12-06 CA CA2672134A patent/CA2672134C/en active Active
- 2007-12-06 BR BRPI0719394 patent/BRPI0719394A2/pt not_active Application Discontinuation
- 2007-12-06 CN CNA2007800447954A patent/CN101600430A/zh active Pending
- 2007-12-06 WO PCT/JP2007/073550 patent/WO2008072534A1/ja active Application Filing
- 2007-12-06 EP EP07850166A patent/EP2100609A4/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
EP2100609A4 (en) | 2010-01-06 |
WO2008072534A1 (ja) | 2008-06-19 |
CA2672134C (en) | 2015-02-10 |
US20100004279A1 (en) | 2010-01-07 |
CA2672134A1 (en) | 2008-06-19 |
EP2100609A1 (en) | 2009-09-16 |
KR20090086423A (ko) | 2009-08-12 |
TWI428151B (zh) | 2014-03-01 |
JPWO2008072534A1 (ja) | 2010-03-25 |
CN101600430A (zh) | 2009-12-09 |
JP5289975B2 (ja) | 2013-09-11 |
KR101442862B1 (ko) | 2014-09-22 |
TW200831137A (en) | 2008-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LTPA2018005I1 (lt) | Farmacinė kompozicija | |
BRPI0719394A2 (pt) | Preparação medicinal sólida | |
BRPI0715712A2 (pt) | Composição farmacêutica | |
BRPI0820381A2 (pt) | Formulações farmacêuticas | |
DK2041139T3 (da) | Farmaceutiske forbindelser | |
DK2073795T3 (da) | Misbrugssikret lægemiddelformulation | |
BRPI0807453A2 (pt) | Preparação sólida | |
BRPI0719393A2 (pt) | Composição farmacêutica | |
BRPI0721651A2 (pt) | Composição farmacêutica | |
DK2399579T3 (da) | Farmaceutiske doseringsformer | |
DK1986650T3 (da) | Manipulationssikre doserignsformer | |
DK3492069T3 (da) | Farmaceutiske sammensætninger omfattende jern-oxy-hydroxid | |
HK1125295A1 (en) | Microtablet-based pharmaceutical preparation | |
ATE450271T1 (de) | Impfstoff | |
BRPI0716445A2 (pt) | composiÇço farmacÊutica | |
BRPI0720234A2 (pt) | Composição farmacêutica | |
DK2120884T3 (da) | Farmaceutisk sammensætning | |
DK1957073T3 (da) | Lægemiddel | |
DK2035369T3 (da) | Terapeutiske | |
DK2125048T3 (da) | Præparat | |
BRPI0719398A2 (pt) | Composição farmacêutica. | |
BRPI0820198A2 (pt) | composições farmacêuticas | |
DK2182988T3 (da) | Radiofarmaceutisk præparat | |
PL2002828T3 (pl) | Stały preparat farmaceutyczny | |
DK2001445T3 (da) | Farmaceutiske sfæroider |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07E | Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] | ||
B12B | Appeal: appeal against refusal [chapter 12.2 patent gazette] |